article · Molecules
Multidrug-resistant (MDR) <i>Escherichia coli</i> is a major foodborne pathogen posing a critical threat to public health, particularly through the contamination of animal products. The increasing prevalence and virulence of MDR <i>E. coli</i> strains underscore the urgent need for alternative antimicrobial strategies. This study aimed to synthesize and characterize zinc oxide nanoparticles (ZnO-NPs) using <i>Stevia rebaudiana</i> as a sustainable capping and reducing agent, aligning with green chemistry principles. Of the 120 fish samples, 74.2% (89/120) were positive for <i>E. coli</i> contamination. Among the identified <i>E. coli</i> strains, 77.8% (119/153) were classified as MDR. Resistance profiling revealed 22 distinct patterns, and seven highly resistant and virulent strains were selected for further analyses. The eco-friendly auto-combustion synthesis of ZnO-NPs produced nanoparticles with semi-spherical to hexagonal shapes and an average size ranging from 12 to 25 nm. Scanning Electron Microscope-Energy Dispersive X-ray analysis (SEM-EDS) confirms that ZnO-NPs primarily consist of zinc (37.5%) and oxygen (19.9%), with carbon (42.6%) indicating the green synthesis process. ZnO-NPs demonstrated potent, dose-dependent antibacterial and antibiofilm activity against the selected MDR <i>E. coli</i> strains. Additionally, mechanistic studies revealed that ZnO-NPs disrupt bacterial cell membranes, alter cellular morphology, and interfere with DNA integrity. These findings highlight the potential of eco-friendly ZnO-NPs as a promising nanomaterial for enhancing food safety and addressing the growing challenge of MDR foodborne bacteria.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.3390/molecules30040768
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.